Evidence map›Paper›PMID 34743171›Full record

ArticleNPJ vaccines2021

Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.

Kevin O Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura Sutherland, Richard Scearce, Maggie Barr, Amanda Eaton, Giovanna Hernandez and 19 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 1 country.

Kevin O SaundersDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.ORCID http://orcid.org/0000-0001-7399-7954
Norbert PardiDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Robert ParksDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Sampa SantraBeth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8796-1714
Zekun MuDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0003-4093-8346
Laura SutherlandDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Richard ScearceDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Maggie BarrDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Amanda EatonDepartment of Surgery, Duke School of Medicine, Durham, NC, USA.
Giovanna HernandezDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Derrick GoodmanDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Michael J HoganDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6244-2993
Istvan TombaczDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
David N GordonBioqual Inc., Rockville, Maryland, USA.
R Wes RountreeDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Yunfei WangDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Mark G LewisBioqual Inc., Rockville, Maryland, USA.
Theodore C PiersonLaboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
Chris BarbosaAcuitas Therapeutics, Vancouver, BC, CA, USA.
Ying TamAcuitas Therapeutics, Vancouver, BC, CA, USA.
Gary R MatyasLaboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
Mangala RaoLaboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
Zoltan BeckLaboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
Xiaoying ShenDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Guido FerrariDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Georgia D TomarasDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
David C MontefioriDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
Drew WeissmanDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA. dreww@pennmedicine.upenn.edu.
Barton F HaynesDuke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA. barton.haynes@dm.duke.edu.ORCID http://orcid.org/0000-0002-7643-9023
Duke University · USUniversity of Pennsylvania · USBioqual · USWalter Reed Army Institute of Research · USBeth Israel Deaconess Medical Center · USHenry M. Jackson Foundation · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34743171
PMCPMC8572283
OpenAlexW3213803375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.